# Managing medication-related osteonecrosis of jaw: A prospective observational study

## TL;DR

This study examines how well current treatments work for a jaw condition caused by certain medications, finding that combining conservative and surgical approaches improves healing and quality of life.

## Contribution

The study provides new evidence supporting the effectiveness of combined conservative and surgical interventions in managing medication-related osteonecrosis of the jaw.

## Key findings

- Combined conservative and surgical interventions improved healing rates in patients with MRONJ.
- Symptom control and quality of life improved over 12 months with the combined treatment approach.
- Stage-based protocols should be refined to optimize therapeutic outcomes for MRONJ patients.

## Abstract

Medication-related osteonecrosis of the jaw (MRONJ) remains a significant clinical challenge due to its complex etiology and variable
response to treatment. This prospective observational study evaluated the effectiveness of current management protocols in 130 patients
receiving antiresorptive or antiangiogenic therapies. Patients were assessed clinically and radiographically and treated according to
standardized stage-specific guidelines. Combined conservative and surgical interventions achieved better healing rates, symptom control,
and improved quality of life over 12 months. These findings support ongoing refinement of stage-based MRONJ protocols to optimize
therapeutic outcomes and patient care.